Wolvers D A, van der Cammen M J, Kraal G
Department of Cell Biology and Immunology, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands.
Immunology. 1997 Nov;92(3):328-33. doi: 10.1046/j.1365-2567.1997.00356.x.
Intranasal administration of protein antigen is an efficient way to induce mucosal tolerance. Suppressive mechanisms that might be involved in this phenomenon include down-regulation of T-helper type-1 (Th1)-mediated processes by Th2 cells. However, since Th2 responses can also be subjected to mucosal tolerance, we wanted to investigate whether suppression of a typical Th1 response, such as a delayed-type hypersensitivity (DTH) reaction by intranasal tolerance induction, was causally related to up-regulation of Th2 responses. We therefore treated mice either systemically or locally with anti-interleukin-4 (IL-4) or anti-IL-10 antibodies before intranasal tolerance induction or before sensitization for DTH to see whether we could prevent or abrogate tolerance. Although the up-regulation of antigen-specific IgE levels in tolerant mice could be prevented by anti-IL-4 treatment, the extent of tolerance as measured by suppression of DTH was not affected. We therefore conclude that up-regulation of Th2 responses observed after intranasal tolerance induction is an additional or consequential rather than a necessary reaction.
经鼻内给予蛋白质抗原是诱导黏膜耐受的有效方法。可能参与这一现象的抑制机制包括2型辅助性T细胞(Th2)对1型辅助性T细胞(Th1)介导过程的下调。然而,由于Th2反应也可受到黏膜耐受的影响,我们想研究经鼻内诱导耐受对典型Th1反应(如迟发型超敏反应(DTH))的抑制是否与Th2反应的上调存在因果关系。因此,我们在经鼻内诱导耐受前或致敏DTH前,用抗白细胞介素-4(IL-4)或抗IL-10抗体对小鼠进行全身或局部处理,以观察是否能预防或消除耐受。尽管抗IL-4处理可预防耐受小鼠中抗原特异性IgE水平的上调,但通过DTH抑制所测得的耐受程度并未受到影响。因此,我们得出结论,经鼻内诱导耐受后观察到的Th2反应上调是一种附加或继发反应,而非必要反应。